In the GSE21653 breast cancer cohort, P4HA2 expression showed significant differences across tumor grades, with highest expression in G3 (Figure 14E), while in the TCGA-BRCA cohort, P4HA2 expression differed significantly across tumor stages, with highest expression in stage 4 (Figure 14F-G). Here, P4HA2 is linked to breast carcinoma.